Page last updated: 2024-08-25

s20098 and Fatty Liver

s20098 has been researched along with Fatty Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Anhê, GF; Bordin, S; de Souza, DN; Hecht, FB; Murata, GM; Pioli, MR; Santos-Silva, JC; Teixeira, CJ; Veronesi, VB; Vicente, JM	1

Other Studies

1 other study(ies) available for s20098 and Fatty Liver

Article	Year
Agomelatine reduces circulating triacylglycerides and hepatic steatosis in fructose-treated rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 141 Topics: Acetamides; Animals; Apolipoproteins B; Body Weight; Carrier Proteins; Energy Intake; Fatty Liver; Fructose; Hypertriglyceridemia; Hypolipidemic Agents; Lipid Metabolism; Lipoproteins, VLDL; Liver; Male; Melatonin; Olive Oil; Rats; Rats, Wistar; Receptors, Melatonin; Triglycerides	2021

Article

Year

Agomelatine reduces circulating triacylglycerides and hepatic steatosis in fructose-treated rats.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 141

Topics: Acetamides; Animals; Apolipoproteins B; Body Weight; Carrier Proteins; Energy Intake; Fatty Liver; Fructose; Hypertriglyceridemia; Hypolipidemic Agents; Lipid Metabolism; Lipoproteins, VLDL; Liver; Male; Melatonin; Olive Oil; Rats; Rats, Wistar; Receptors, Melatonin; Triglycerides

2021